| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |